# Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer

> **NCT00008060** · PHASE3 · COMPLETED · sponsor: **Medical Research Council**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** FOLFIRI regimen
- **DRUG:** FOLFOX regimen
- **DRUG:** fluorouracil
- **DRUG:** irinotecan hydrochloride
- **DRUG:** leucovorin calcium
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00008060
- **Lead sponsor:** Medical Research Council
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00008060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00008060, "Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00008060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*